fluorescein sodiumcorneal abrasions
…tear film stability, and to measure intraocular pressure. Since fluorescein sodium ophthalmic strips are not commercially available in our market,…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Funders
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentions29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed
Popular entities in these results
Choose an entity to see the articles in which it was identified.
EMBASE784PUBMED717COVID-19645Cancer605SLE570Diabetes552NHS522WEB OF SCIENCE499Hypertension418SCOPUS417HIV406Systemic Lupus Erythematosus390Heart Failure364Asthma349Stroke336COPD331WHO330Colorectal Cancer327Cardiovascular Disease317Type 2 Diabetes316Chronic Obstructive Pulmonary Disease313Joanna Briggs Institute306MEDLINE306Atrial Fibrillation283Cochrane Library275Breast Cancer271Hepatocellular Carcinoma253SSc251Inflammatory Bowel Disease250Obesity246
Matching articles
29,499 articles · page 230 of 2459amoxicillinosteomyelitislevofloxacinendocarditissulfamethoxazole/trimethoprimcotrimoxazolerifampicinapixabanabscesseslong-term antibiotic therapies+2 more
…re sulfamethoxazole/trimethoprim (24%), levofloxacin (20%), and amoxicillin (19%). A total of 21 pharmaceutical interventions (PIs) were pe…
propranololmetoprololbisoprololhaemangiomasarterial hypertensionDivision of PaediatricsarrhythmiasATC group C07congenital malformations of the circulatory systemtachycardia
…d for use in children: metoprolol for arterial hypertension and propranolol for arrhythmias and haemangiomas. The use of these medications …
faricimabafliberceptdiabetic macular oedemabevacizumabmacular oedemaHospitaldexamethasoneretinal vein occlusionRVODME
…tion therapy with anti-VEGF agents (aflibercept, bevacizumab or faricimab) and one eye received three treatments.The average number of ad…
99.4%
faricimabAfliberceptbevacizumabAge-related macular degeneration (AMD)anti-angiogenic therapy
…ti-angiogenic therapy, mainly aflibercept and bevacizumab, with faricimab as a second-line option. Personalised treatments and optimised …
diureticsDRPsWorld-Health-Organisation-Uppsala-Monitoring-Centreantithrombotic agentspsycholepticspsychoanalepticsclinical pharmaceutical interventions
…tithrombotic agents’, ‘psycholeptics’, ‘psychoanaleptics’, and ‘diuretics’. In 75% (48/64) of DRPs, clinical pharmaceutical interventions…
HER2-positive metastatic breast cancermetastatic breast cancerHER2-low metastatic breast cancerHER2-low diseaseunresectable or metastatic breast cancerHER2-low unresectable or metastatic breast cancerHER2-positive unresectable or metastatic breast cancerT-DXdTrastuzumab deruxtecanHER2-positive disease
…n (T-DXd) is an antibody–drug conjugate with proven efficacy in HER2-positive metastatic breast cancer and, more recently, in HER2-low disease. However, real-world da…
pembrolizumabNICECanadian Agency for DrugsCADTHTechnologies in HealthNational Health Service in EnglandEuropean Medicines Agency
…tional Health Service in England (NICE) have recommended dosing pembrolizumab by weight.3 4 Aim and Objectives To assess the economic impact …
prasugrelabacavircodeinepercutaneous coronary interventionticagrelorAdverse drug reactionsclopidogrelEuropean Medicines AgencyDutch Pharmacogenetics Working GroupUS Food and Drug Administration+6 more
…:CYP2C19–clopidogrel: in poor/intermediate metabolisers, prefer prasugrel or ticagrelor after percutaneous coronary intervention.HLA–B*57…
Chronic kidney diseasemetforminclinical alert programallopurinoltype 2 diabeteshypertension
…Background and Importance Chronic kidney disease is a major health problem. When chronic kidney disease progress…
WHOAntibioticsGerman university hospitalABS ward rounds
…Background and Importance In 2017, the WHO classified antibiotics into Access, Watch, and Reserve groups t…
tertiary paediatric hospitalDextromethorphan (DXM)MTXMTX-neurotoxicityDXMMethotrexatetoxic leukoencephalopathy
… treatment and/or prophylaxis of MTX-related neurotoxicity in a tertiary paediatric hospital.Material and Methods Retrospective observational study of paedi…